Trial Profile
A Randomised, Open-Label, Assessor-Blind, Parallel Groups, Multicentre Trial Comparing the Efficacy of MENOPUR Versus Recombinant FSH in Controlled Ovarian Stimulation Following a GnRH Antagonist Protocol and Single Embryo Transfer
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 07 Oct 2021
Price :
$35
*
At a glance
- Drugs Menotropin (Primary) ; Choriogonadotropin alfa; Follitropin beta; Ganirelix; Gonadotropins; Progesterone
- Indications Female infertility
- Focus Therapeutic Use
- Acronyms MEGASET
- Sponsors Ferring Pharmaceuticals
- 19 Apr 2012 Actual patient number changed from (754) to (749) as reported by ClinicalTrials.gov.
- 19 Apr 2012 Actual end date (Jan 2011) added as reported by ClinicalTrials.gov.
- 19 Apr 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.